The performance of all the two-gene marker panels (HOXA9 + SOX1) and (HIC1 + SOX1) was found significant and the gene panels differentiated cancer vs normal with a higher accuracy in serum samples (Supplementary File 1: Table S2). This evidence concerns the gene SOX1 and cancer.